Prof. Dr. Jörg Huwyler
Jörg Huwyler
Philosophisch-Naturwissenschaftliche Fakultät
Departement Pharmazeutische Wissenschaften
Pharmazeutische Technologie


Klingelbergstrasse 50
4056 Basel

Tel. +41 61 207 15 13

Jörg Huwyler obtained a Ph.D. in biochemistry at the Biocenter of the University of Basel. In 1993, he joined the group of Prof. J. Drewe as a postdoctoral fellow at the University Hospital of Basel, followed by an appointment at the Brain Research Institute, UCLA School of Medicine, Los Angeles, with Prof. W.M. Pardridge. In 1998, he became deputy group leader at the Institute of Medical Research in Basel. From 1999 - 2006 he joined the pharmaceutical industry, where he worked as DMPK project leader for F. Hoffmann-La Roche in Basel, Switzerland. In 2003, he obtained his habilitation in Pharmacy. He served as Professor of Biopharmacy and Pharmaceutical Technology from 2006 - 2010 at the University of Applied Sciences (FHNW) in Basel. In 2010, he was appointed head of the Division of Pharmaceutical Technology, Department of Pharmaceutical Sciences, University of Basel.

He is the author of 142 peer-reviewed original research articles, 15 review articles, reports & book chapters, 6 technical reports and holds 13 patents.

Schittny, A., Huwyler, J. und Puchkov, M. (2020) «Mechanisms of increased bioavailability through amorphous solid dispersions: a review», Drug delivery. Taylor and Francis, 27(1), S. 110-127. doi: 10.1080/10717544.2019.1704940.   edoc
Suenderhauf, C., Berger, B., Puchkov, M., Schmid, Y., Müller, S., Huwyler, J., Haschke, M., Krähenbühl, S. und Duthaler, U. (2020) «Pharmacokinetics and phenotyping properties of the ‹Basel› phenotyping cocktail combination capsule in healthy male adults», British journal of clinical pharmacology. Wiley, 86(2), S. 352-361. doi: 10.1111/bcp.14157.   edoc
Häuser, C., Goldbach, P., Huwyler, J., Friess, W. und Allmendinger, A. (2020) «Excipients for Room Temperature Stable Freeze-Dried Monoclonal Antibody Formulations», Journal of Pharmaceutical Sciences. Elsevier, 109(1), S. 807-817. doi: 10.1016/j.xphs.2019.10.016.   edoc
Titel Status
Development of novel synthetic gene transfer vectors for metabolic liver therapy Laufend
High Performance Transmission Electron Microscope for Present and Future Nanomaterials Abgeschlossen
Drug Targeting to Hepatocytes: Gene Delivery using Myrcludex B Coupled Lipid Nanoparticles Abgeschlossen